Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20
What Are The Growth Projections For The Adrenal Cancer Diagnostics Market Size During 2025–2029?
The adrenal cancer diagnostics market has shown substantial growth over recent years. Its valuation is anticipated to increase from $140.35 billion in 2024 to $148.54 billion in 2025, exhibiting a compound annual growth rate (CAGR) of 5.8%. The expansion observed in prior periods can be attributed to factors such as a heightened incidence and understanding of the condition, innovations in genetic and molecular testing, refinements in biopsy methodologies, improved endocrine testing, and the incorporation of artificial intelligence (AI).
The adrenal cancer diagnostics market is anticipated to undergo substantial growth over the next few years. It is projected to expand to $190.8 billion by 2029, achieving a compound annual growth rate (CAGR) of 6.5%. This growth throughout the forecast period is attributable to factors such as personalized medicine approaches, an increase in minimally invasive procedures, the rise of telemedicine and remote consultations, developments in liquid biopsy, and the expansion of genetic counseling services. Prominent trends for the forecast period include regulatory backing for diagnostic innovations, the widespread adoption of digital pathology, ongoing advancements in imaging technologies, continued liquid biopsy development, and the utilization of genomic profiling for precision medicine.
Unlock Your Free Sample Report for Exclusive Market Data:
https://www.thebusinessresearchcompany.com/sample.aspx?id=13242&type=smp
What Are The Key Drivers Of Growth In The Adrenal Cancer Diagnostics Market?
The escalating trend of cigarette smoking is anticipated to propel the expansion of the adrenal cancer diagnostics market in the forthcoming period. Cigarette smoking describes the process of inhaling and exhaling the vapor from ignited tobacco, which contains nicotine, an addictive alkaloid with both stimulating and calming psychoactive effects. A heightened risk of adrenal cancer, encompassing adrenal adenomas and adrenocortical carcinomas, has been associated with cigarette smoking. The carcinogenic agents found in tobacco smoke can inflict damage upon the DNA within adrenal cells, instigating mutations that have the potential to cause cancer. As an illustration, Statistics Canada, a Canada-based government agency, reported in July 2022 that cigarette production climbed by 5.8% when compared to June 2021. Moreover, the aggregate number of cigarettes sold increased by 1.3% from May 2022, reaching 1.4 billion in June 2022. Thus, the growing prevalence of cigarette smoking is a key driver for the adrenal cancer diagnostics market’s growth.
What Are The Emerging Segments Gaining Attention In The Adrenal Cancer Diagnostics Market?
The adrenal cancer diagnosticsmarket covered in this report is segmented –
1) By Test: Magnetic Resonance Imaging (MRI); Computed Tomography (CT) Scan; X-ray; Positron Emission Tomography (PET) Scan; Biopsy
2) By Treatment: Surgery; Chemotherapy; Radiotherapy; Targeted Cancer Therapies; Other Treatments
3) By Tumor Type: Pheochromocytoma; Adrenal Cortical Carcinoma; Other Types
4) By End-User: Hospitals; Ambulatory Surgical Centers; Cancer Centers; Other End-Users
Subsegments:
1) By Magnetic Resonance Imaging (MRI): Contrast-Enhanced MRI; Functional MRI
2) By Computed Tomography (CT) Scan: Contrast-Enhanced CT; Abdomen And Pelvis CT Scans
3) By X-ray: Standard X-ray Imaging; Specialized X-ray Techniques
4) By Positron Emission Tomography (PET) Scan: PET-CT Combination Scans; Standalone PET Scans
5) By Biopsy: Fine Needle Aspiration Biopsy (FNA); Core Needle Biopsy; Surgical Biopsy
What Trends Are Redefining The Adrenal Cancer Diagnostics Market Dynamics?
Leading companies within the adrenal cancer diagnostics market are implementing novel initiatives that incorporate advanced collaboration models, such as the CancerX Startup Accelerator, aimed at enhancing digital advancements in cancer care. This Accelerator endeavors to provide promising startups with essential mentorship, training, and direct access to significant participants in the healthcare sector, including service providers and pharmaceutical firms. For example, in November 2023, CanceRx, LLC, a US-based public-private partnership established to boost innovation in the fight against cancer, announced the launch of this initiative during the Future of Cancer Care Summit in Tampa, Florida. The program is slated to select its initial cohort of approximately 15 to 20 companies starting in March 2024, with a focus on crucial themes like clinical research, screening, diagnosis, and treatment. It is anticipated to substantially propel the objectives of the Cancer Moonshot initiative by addressing unfulfilled requirements in cancer care and fostering the creation of effective digital health instruments in oncology.
Who Are The Primary Competitors In The Global Adrenal Cancer Diagnostics Market?
Major companies operating in the adrenal cancer diagnostics market report are Johnson And Johnson Pvt Ltd., F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific, GSK PLC, AstraZeneca PLC, Abbott Laboratories, Siemens Healthcare GmbH, Becton Dickinson and Company, Koninklijke Philips N.V., GE HealthCare Technologies Inc., Agilent Technologies, Hologic Inc., PerkinElmer Inc., Illumina Inc., Roche Diagnostics, BioMerieux SA, Sysmex Corporation, Bio-Rad Laboratories Inc., Bruker Corporation, Exact Sciences Corp., Natera Inc., Invitae Corporation, Qiagen NV, Guardant Health Inc., Foundation Medicine Inc., NanoString Technologies Inc., TRS Technologies Inc., Morgan Advanced Materials, APC International Ltd., Annon Piezo Technology Co. Limited
Download The Full Report For Exclusive Market Findings:
https://www.thebusinessresearchcompany.com/report/adrenal-cancer-diagnostics-global-market-report
What Regional Growth Trends Are Shaping The Adrenal Cancer Diagnostics Market Outlook?
North America was the largest region in the adrenal cancer diagnostics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the adrenal cancer diagnostics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Request A Customized Version Of The Adrenal Cancer Diagnostics Market Report:
https://www.thebusinessresearchcompany.com/customise?id=13242&type=smp
Browse Through More Reports Similar to the Global Adrenal Cancer Diagnostics Market 2025, By The Business Research Company
Breast Cancer Drugs Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/breast-cancer-drugs-global-market-report
Cancer Diagnostics Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/cancer-diagnostics-global-market-report
Cervical Cancer Diagnostics Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/cervical-cancer-diagnostics-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model